Manning & Napier Advisors LLC Has $107.56 Million Holdings in Intuitive Surgical, Inc. $ISRG

Manning & Napier Advisors LLC decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 240,493 shares of the medical equipment provider’s stock after selling 9,431 shares during the quarter. Intuitive Surgical makes up approximately 1.4% of Manning & Napier Advisors LLC’s portfolio, making the stock its 27th biggest position. Manning & Napier Advisors LLC owned 0.07% of Intuitive Surgical worth $107,556,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Norges Bank bought a new stake in shares of Intuitive Surgical during the second quarter worth about $2,569,260,000. Vanguard Group Inc. boosted its position in Intuitive Surgical by 2.1% during the 2nd quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock worth $18,115,025,000 after buying an additional 670,302 shares during the period. Jennison Associates LLC grew its holdings in Intuitive Surgical by 20.4% during the 2nd quarter. Jennison Associates LLC now owns 3,122,390 shares of the medical equipment provider’s stock worth $1,696,738,000 after acquiring an additional 528,359 shares during the last quarter. Bessemer Group Inc. increased its position in Intuitive Surgical by 89.3% in the 2nd quarter. Bessemer Group Inc. now owns 788,328 shares of the medical equipment provider’s stock valued at $428,386,000 after acquiring an additional 371,806 shares during the period. Finally, Assenagon Asset Management S.A. increased its position in Intuitive Surgical by 25.1% in the 2nd quarter. Assenagon Asset Management S.A. now owns 1,582,280 shares of the medical equipment provider’s stock valued at $859,827,000 after acquiring an additional 317,324 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Henry L. Charlton sold 13,731 shares of the stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total value of $7,963,980.00. Following the transaction, the executive vice president owned 3,056 shares in the company, valued at approximately $1,772,480. This represents a 81.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Gary S. Guthart sold 28,800 shares of the firm’s stock in a transaction that occurred on Friday, October 24th. The shares were sold at an average price of $547.56, for a total value of $15,769,728.00. Following the completion of the sale, the insider directly owned 27,027 shares of the company’s stock, valued at $14,798,904.12. This trade represents a 51.59% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 114,007 shares of company stock worth $63,533,844 in the last quarter. Company insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently commented on ISRG shares. Leerink Partners lifted their price target on shares of Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a report on Wednesday, October 22nd. Royal Bank Of Canada lifted their target price on Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a report on Wednesday, December 17th. Robert W. Baird set a $655.00 price target on Intuitive Surgical in a research report on Wednesday, October 22nd. Rothschild & Co Redburn increased their price target on Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Finally, UBS Group set a $600.00 target price on Intuitive Surgical and gave the company a “neutral” rating in a report on Thursday, October 23rd. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $622.17.

Intuitive Surgical Stock Down 1.9%

Shares of NASDAQ ISRG opened at $561.82 on Wednesday. The firm has a market cap of $201.40 billion, a PE ratio of 74.31, a P/E/G ratio of 4.66 and a beta of 1.67. The company’s fifty day simple moving average is $566.99 and its 200 day simple moving average is $511.85. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating the consensus estimate of $1.99 by $0.41. The firm had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The business’s quarterly revenue was up 22.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.84 earnings per share. On average, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.